Advertisement

Chronic Otitis Media

  • Jennifer J. Shin
  • J. Gail Neely
  • Ming-Yee Lin
  • Steven D. Rauch
  • Saumil Merchant

Abstract

A computerized PubMed search of MEDLINE 1966-December 2005 was performed. The medical subject heading “otitis media, suppurative” was exploded and the resulting articles were cross-referenced with those mapping to the subject headings “anti-bacterial agents,” “macrolides,” “fluoroquinolones,” “clindamycin,” or “lactams,” yielding 227 publications. These articles were then reviewed to identify those that met the following inclusion criteria: 1) patient population without cholesteatoma with discharging ears through a chronic perforation, 2) intervention with topical antibiotic drops versus placebo or antiseptic drops, 3) outcome measured in terms of cessation of otorrhea. Because of the richness of the literature, randomized controlled trials (RCTs) were specifically extracted as the best evidence available. Articles in which random allocation could not be confirmed or in which other interventions were allowed were excluded. The bibliographies of the articles that met these inclusion criteria and relevant reviews were manually checked to ensure no further relevant articles could be indentified.

Keywords

Hearing Loss Otitis Medium Sensorineural Hearing Loss Chronic Otitis Medium Bone Conduction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Browning GG, Gatehouse S, Calder IT. Medical management of active chronic otitis media: a controlled study. J Laryngol Otol 1988;102(6):491.CrossRefPubMedGoogle Scholar
  2. 2.
    van Hasselt P, van Kregten E. Treatment of chronic suppurative otitis media with ofloxacin in hydroxypropyl methylcellulose ear drops: a clinical/bacteriological study in a rural area of Malawi. Int J Pediatr Otorhinolaryngol 2002;63(1): 49–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Kasemsuwan L, Clongsuesuek P. A double blind, prospective trial of topical ciprofloxacin versus normal saline solution in the treatment of otorrhoea. Clin Otolaryngol Allied Sci 1997;22(1):44–46.CrossRefPubMedGoogle Scholar
  4. 4.
    Macfadyen C, Gamble C, Garner P, et al. Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Trop Med Int Health 2005; 10(2):190.CrossRefPubMedGoogle Scholar
  5. 5.
    Fradis M, Brodsky A, Ben-David J, Srugo I, Larboni J, Podoshin L. Chronic otitis media treated topically with ciprooxacin or tobramycin. Arch Otolaryngol Head Neck Surg 1997;123(10):1057.PubMedGoogle Scholar
  6. 6.
    Jaya C, Job A, Mathai E, Antonisamy B. Evaluation of topical povidone-iodine in chronic suppurative otitis media. Arch Otolaryngol Head Neck Surg 2003;129(10):1098.CrossRefPubMedGoogle Scholar
  7. 7.
    Browning GG, Picozzi GL, Calder IT, Sweeney G. Controlled trial of medical treatment of active chronic otitis media. Br Med J Clin Res Ed 1983;287(6398):1024.CrossRefPubMedGoogle Scholar

References

  1. 1.
    Esposito S, Noviello S, D’Errico G, Montanaro C. Topical ciprofloxacin versus intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg 1992; 118(8):842.PubMedGoogle Scholar
  2. 2.
    Esposito S, D’Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. Arch Otolaryngol Head Neck Surg 1990;116(5):557.PubMedGoogle Scholar
  3. 3.
    Yuen PW, Lau SK, Chau P, et al. Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study. Am J Otol 1994;15(5):670.PubMedGoogle Scholar
  4. 4.
    Browning GG, Picozzi GL, Calder IT, Sweeney G. Controlled trial of medical treatment of active chronic otitis media. Br Med J Clin Res Ed 1983;287(6398):1024.CrossRefPubMedGoogle Scholar

References

  1. 1.
    Supiyaphun P, Kerekhanjanarong V, Koranasophonepun J, Sastarasadhit V. Comparison of ofloxacin otic solution with oral amoxicillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation. J Med Assoc Thai 2000;83(1):61.PubMedGoogle Scholar
  2. 2.
    Esposito S, D’Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. Arch Otolaryngol Head Neck Surg 1990;116(5):557.PubMedGoogle Scholar

References

  1. 1.
    Welling DB, Forrest LA, Goll F III. Safety of ototopical antibiotics. Laryngoscope 1995;105:472–474.CrossRefPubMedGoogle Scholar
  2. 2.
    Rakover Y, Keywan K, Rosen G. Safety of topical ear drops containing ototoxic antibiotics. J Otolaryngol 1989;193(1): 46–50.Google Scholar
  3. 3.
    Podoshin L, Fradis M, Ben David J. Ototoxicity of ear drops in patients suffering from chronic otitis media. J Largyngol Otol 1989;193(1):46–50.Google Scholar
  4. 4.
    Merifield DO, Parker NJ, Nicholson N. Therapeutic management of chronic suppurative otitis media with otic drops. Otolaryngol Head Neck Surg 1993;109:77–82.PubMedGoogle Scholar
  5. 5.
    Linder TE, Zwicky S, Bränle. Ototoxicity of ear drops: a clinical perspective. Am J Otol 1995;16.Google Scholar
  6. 6.
    Lundy LB, Graham MD. Ototoxicity and ototopical medications: a survey of otolaryngologists. Am J otol 1993;14:141–146.PubMedGoogle Scholar

References

  1. 1.
    Charachon R, Gratacap B, Elbaze D. Anatomical and functional reconstruction of old mastoidectomy cavities by obliteration tympanoplasty. Clin Otolaryngol 1989;14:121–126.CrossRefPubMedGoogle Scholar
  2. 2.
    Characon R, LeJune JM, Bouchal H. Reconstrutions of radical mastoidectomy by obliteration technique. Ear Nose Throat J 1991;70(12):830–838.Google Scholar
  3. 3.
    Minatogawa T, Jumoi T, Inamori T, Oki K, Machizuka H. Hyogo Ear Bank experience with allograft tympanoplasty: review of tympanoplasty on 68 ears. Am J Otol 1990; 11(3):157–163.PubMedGoogle Scholar
  4. 4.
    Nomura K, Lino Y, Hashimoto H, Suzuki J-I, Kazuoki K. Hearing results after tympanoplasty in elderly patients with middle ear cholesteatoma. Acta Otolaryngol 2001; 121:919–924.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Jennifer J. Shin
    • 1
  • J. Gail Neely
    • 2
  • Ming-Yee Lin
    • 3
  • Steven D. Rauch
    • 4
  • Saumil Merchant
    • 5
  1. 1.Harvard Program in Otolaryngology-Head and Neck SurgeryMassachusetts Eye and Ear InfirmaryBostonUSA
  2. 2.Department of OtolaryngologyBarnes-Jewish HospitalSt. LouisUSA
  3. 3.Department of OtolaryngologyVeteran General HospitalKao-hsiungTaiwan
  4. 4.Department of OtolaryngologyMassachusetts Eye and Ear InfirmaryBostonUSA
  5. 5.Department of Otology and Laryngology, Harvard Medical School, Gudrun Larsen Eliasen and Nels Kristian Eliasen Professor of Otology and Laryngology, Otology ServiceMassachusetts Eye and Ear InfirmaryBostonUSA

Personalised recommendations